mHA

DRUG2 trials

Sponsors

University Hospital Muenster, St. Jude Children's Research Hospital

Conditions

Chronic PeriodontitisMyeloid Neoplasm

Phase 2

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Active, not recruitingNCT05656248

St. Jude Children's Research HospitalMyeloid Neoplasm

Start: 2023-01-17End: 2028-08-01Updated: 2026-06-25

Unknown Phase

Plaque Formation Rate and Toothpaste

CompletedNCT02697539

University Hospital MuensterChronic Periodontitis

Start: 2011-03-31End: 2011-12-31Updated: 2016-03-03

Related Papers

A prospective, single site, single-arm pilot study of CPX-351 (Vyxeos) in individuals &lt;22 years with secondary myeloid neoplasms

Blood2025-11-03

Impact of the Daily Use of a Microcrystal Hydroxyapatite Dentifrice on De Novo Plaque Formation and Clinical/Microbiological Parameters of Periodontal Health. A Randomized Trial

PLoS ONE2016-07-2848 citations